[go: up one dir, main page]

Semina et al., 2016 - Google Patents

The role of urokinase in vascular cell migration and in regulation of growth and branching of capillaries

Semina et al., 2016

View PDF
Document ID
9551380864502911658
Author
Semina E
Rubina K
Sysoeva V
Makarevich P
Parfyonova Y
Tkachuk V
Publication year
Publication venue
Cell and Tissue Biology

External Links

Snippet

The urokinase system, represented by a plasminogen activator of urokinase type (urokinase, uPA), urokinase receptor (uPAR), and inhibitors of plasminogen activator (PAI-1 and PAI-2), plays an important role in the regulation of vascular wall functioning. Urokinase signaling …
Continue reading at istina.msu.ru (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue

Similar Documents

Publication Publication Date Title
Crisera et al. Expression and role of laminin-1 in mouse pancreatic organogenesis.
Ardi et al. Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway
Nicosia The aortic ring model of angiogenesis: a quarter century of search and discovery
US8334259B2 (en) Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative
Lutty et al. Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation
ES2217050T3 (en) THE USE OF ISOLATED DOMAINS OF TYPE IV COLLAGEN TO MODIFY THE INTERACTIONS OF CELLS AND FABRICS.
Mazharian et al. Differential involvement of ERK2 and p38 in platelet adhesion to collagen
Sakata et al. Neovessel formation promotes liver fibrosis via providing latent transforming growth factor-β
Kräling et al. A simplified method for growth of human microvascular endothelial cells results in decreased senescence and continued responsiveness to cytokines and growth factors
Mahoney et al. ADAM8 is selectively up‐regulated in endothelial cells and is associated with angiogenesis after spinal cord injury in adult mice
Watanabe et al. Up-regulation of urokinase-type plasminogen activator in corneal epithelial cells induced by wounding
Roncal et al. New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator
Semina et al. The role of urokinase in vascular cell migration and in regulation of growth and branching of capillaries
Onguchi et al. Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization
Wypasek et al. Effects of rivaroxaban and dabigatran on local expression of coagulation and inflammatory factors within human aortic stenotic valves
Ribatti et al. The role of fibroblast growth factor‐2 in the vascularization of the chick embryo chorioallantoic membrane
Lecomte et al. Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization
Ma et al. Cardiac extracellular matrix tenascin-C deposition during fibronectin degradation
US20190255144A1 (en) Specific oligopeptides as anti-angiogenic drugs
Dudnakova et al. Alterations in myocardial ultrastructure and protein expression after a single injection of isoproterenol
Browning The isolation, characterisation and investigation into the In vitro behaviour of human ocular vascular endothelial cells
US6436629B1 (en) Modulating angiogenesis
KRAMER et al. Isolation and characterization of human vascular endothelial cells with application to studies of the subendothelial matrix
Heydarigoojani Thrombin receptor activating peptide-6 (TRAP-6) promotes human umbilical vein endothelial cells proliferation
Deng Regulation of Periosteal Myeloid-Lineage Cells for Cortical Bone Formation